TerSera Therapeutics LLC

acquired/licensed specialty pharmaceuticals (oncology, rare disease, non-opioid pain)

Privately held: no public share price · United States

Assets

(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Approved
GnRH receptor (agonist)Peptide
Breast Cancer
HR+/HER2- Metastatic Breast Cancer
margetuximab(Margenza)
Approved
HER2Monoclonal antibody
Breast Cancer
HER2-Positive Breast Cancer

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.